Research programme: TGFb/retinol nanocapsules - TherapyX

Alternative Names: TGFβ-NanoCap^®

Latest Information Update: 27 Jul 2016

Price : ^*

* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

Originator TherapyX
Class Antineoplastics; Antivirals; Growth factors; Nootropics; Retinoids; Transforming growth factors
Mechanism of Action Transforming growth factor beta type I receptor modulators; Vitamin agonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No
Available For Licensing Yes

Highest Development Phases

Preclinical Inflammatory bowel diseases

Most Recent Events

27 Jul 2016 Research programme: TGFb/retinol nanocapsules - TherapyX is available for licensing - http://therapyxinc.com/pipeline
27 Jul 2016 Preclinical trials in Inflammatory bowel disease in USA (PO)

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login with a username/password associated to an account with a valid subscription
Contact your organization’s admin about adding this content to your AdisInsight subscription
Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.